Phase I study of PS-341 (bortezomib) with 5-fluorouracil/leucovorin (5-FU/LV) in advanced solid tumors: A California Cancer Consortium study.

被引：0
|
作者：
Iqbal, S
Cole, S
Yang, D
Lara, PN
Gumerlock, PH
Shibata, S
Synold, T
Doroshow, JH
Gandara, D
Lenz, HJ
机构：
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Calif Davis, Sacramento, CA USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2057
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [41] A phase II study of neoadjuvant irinatecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for resectable liver metastases from colorectal cancer.
    Bathe, OF
    Ernst, S
    Sutherland, F
    Dixon, E
    Koppel, J
    Butts, C
    Bigam, D
    Ruether, D
    Walley, B
    Dowden, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 286S - 286S
  • [42] Phase I study of topotecan (T) with weekly 5-fluorouracil (5FU)/leucorin (LV) in patients with advanced malignancies
    Axelrod, R. S.
    Rose, L.
    Biermann, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Adjuvant chemotherapy of cisplatin, 5-fluorouracil (5-FU) plus leucovorin (LV) for esophageal cancer: A case-matched cohort study in east china
    Zhang, J.
    Xiang, J.
    Zhang, Y.
    Zhou, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] A prospective randomized phase III trial of adjuvant chemotherapy with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Greil, R.
    Tschmelitsch, J.
    Steger, G.
    Jakesz, R.
    Gnant, M.
    Hofbauer, F.
    Rabl, H.
    Thaler, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] A phase I dose escalation (DE) and pharmacokinetics (PK) study of intravenous aflibercept (VEGF Trap) plus irinotecan, 5-fluorouracil, and leucovorin (I-LV5FU2) in patients with advanced solid tumors (STs)
    Rixe, O.
    Verslype, C.
    Khayat, D.
    Tejpar, S.
    Billemont, B.
    Crabbe, M.
    Meric, J. B.
    Assadourian, S.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies
    Cho, CD
    Fisher, GA
    Halsey, J
    Sikic, BI
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (02) : 117 - 123
  • [47] METHOTREXATE (MTX), 5-FLUOROURACIL (FU) AND LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCER (HNC)
    OHNUMA, T
    COFFEY, V
    KOHNO, N
    BILLER, H
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 209 - 209
  • [48] COMPARATIVE PHASE 2 STUDY OF INFUSIONAL 5, 10-METHYLENETETRAHYDROFOLATE WITH 5-FLUOROURACIL (FU) VERSUS LEUCOVORIN (LV) WITH FU IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cassidy, J.
    Jelic, S.
    Pluzanska, A.
    Ciuleanu, T.
    Babu, K. G.
    Stewart, J.
    Schupp, J. P. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 130 - 130
  • [49] Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies
    Cheryl D. Cho
    George A. Fisher
    Joanne Halsey
    Branimir I. Sikic
    Investigational New Drugs, 2006, 24 : 117 - 123
  • [50] 5-FLUOROURACIL (5-FU), METHYL-CCNU, AND VINCRISTINE IN TREATMENT OF ADVANCED COLORECTAL CANCER - PHASE-2 STUDY UTILIZING WEEKLY 5-FU
    MACDONALD, JS
    KISNER, DF
    SMYTHE, T
    WOOLLEY, PV
    SMITH, L
    SCHEIN, PS
    CANCER TREATMENT REPORTS, 1976, 60 (11): : 1597 - 1600
12345